BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1394173)

  • 1. The past is prologue: use of serum banks in cancer research.
    Evans AS; Mueller NE
    Cancer Res; 1992 Oct; 52(19 Suppl):5557s-5560s. PubMed ID: 1394173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of experimental techniques to epidemiological studies of non-Hodgkin's lymphoma: use of archival tissues.
    Levine PH
    Cancer Res; 1992 Oct; 52(19 Suppl):5561s-5562s; discussion 5562s-5565s. PubMed ID: 1394174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus--associated diseases in humans.
    Kawa K
    Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epstein-Barr, hepatitis B and hepatitis C virus infections and their oncogenic potentials].
    Jovanović J; Brkić S; Klasnja B; Fabri M
    Med Pregl; 1997; 50(11-12):499-504. PubMed ID: 9471511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious agents and cancer: criteria for a causal relation.
    Pagano JS; Blaser M; Buendia MA; Damania B; Khalili K; Raab-Traub N; Roizman B
    Semin Cancer Biol; 2004 Dec; 14(6):453-71. PubMed ID: 15489139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
    Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
    J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of cancer following hospitalization for infection in infancy: a population-based cohort study.
    Paltiel O; Laniado DE; Yanetz R; Deutsch L; Calderon-Margalit R; Harlap S; Friedlander Y
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1964-8. PubMed ID: 17035406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.
    Catalano MA; Carson DA; Niederman JC; Feorino P; Vaughan JH
    J Clin Invest; 1980 May; 65(5):1238-42. PubMed ID: 6245108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on Epstein-Barr virus in patients with primary sinonasal non-Hodgkin's lymphoma].
    Li T; Qiu Q; Li N
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):222-4. PubMed ID: 11717888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma.
    Hogan TF; Padgett BL; Walker DL; Borden EC; Frias Z
    Prog Clin Biol Res; 1983; 105():311-24. PubMed ID: 6304768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.
    Valente G; Secchiero P; Lusso P; Abete MC; Jemma C; Reato G; Kerim S; Gallo RC; Palestro G
    Am J Pathol; 1996 Nov; 149(5):1501-10. PubMed ID: 8909240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.